0001127602-11-018592.txt : 20110603 0001127602-11-018592.hdr.sgml : 20110603 20110603160605 ACCESSION NUMBER: 0001127602-11-018592 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110601 FILED AS OF DATE: 20110603 DATE AS OF CHANGE: 20110603 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAGEMANN ROBERT CENTRAL INDEX KEY: 0001222676 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 11892311 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2011-06-01 0001022079 QUEST DIAGNOSTICS INC DGX 0001222676 HAGEMANN ROBERT C/O QUEST DIAGNOSTICS INCORPORATED 3 GIRALDA FARMS MADISON NJ 07940 1 SVP & Chief Financial Officer Common Stock 2011-06-01 4 M 0 1650 35.5325 A 141302 D Common Stock 2011-06-01 4 M 0 2500 48.74 A 143802 D Common Stock 2011-06-01 4 S 0 2500 58.0886 D 141302 D Common Stock 2011-06-01 4 S 0 1650 58.1101 D 139652 D Common Stock 1760 I SDCP Stock Options (Right to Buy) 35.5325 2011-06-01 4 M 0 1650 0 D 2012-02-27 Common Stock 1650 21450 D Stock Options (Right to Buy) 48.74 2011-06-01 4 M 0 2500 0 D 2012-02-22 Common Stock 2500 32500 D This exercise and sale reported were effected pursuant to Rule 10b-5-1 sales plan adopted by the reporting person on February 7, 2011. The options vested in three installments on April 17, 2003, February 27, 2004 and February 27, 2005. The options vested in three annual installments on February 22, 2006, February 22, 2007 and February 22, 2008. This transaction was executed in multiple trades at prices ranging from $58.02 to $58.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $58.02 to $58.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. These underlying shares were acquired on a periodic basis by the trustee of the Company's Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a recent date. The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments), divided by the market price of the Company's stock as of that date. This amount also includes exempt purchases made under the Company's stock purchase plan. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Robert Hagemann 2011-06-03